Navigation Links
Liberty Institute: Government "Accommodation" Still Requires Employers To Facilitate Coverage Of Abortifacient Drugs
Date:8/22/2014

WASHINGTON, Aug. 22, 2014 /PRNewswire-USNewswire/ -- Today, the Obama Administration issued new regulations under Obamacare that modify the religious "accommodation" but still require religious organizations to facilitate insurance coverage for drugs that have an abortifacient effect, including Plan B (the "morning after pill") and Ella (the "week after pill"). The Obama Administration also announced that it is investigating expanding the "accommodation" to religious, closely held, for-profit corporations.

The regulations issued today keep the same "accommodation" in place but provide an alternative means of accepting the "accommodation." Instead of submitting the previously required form, religious organizations may now elect instead to notify the government in writing of their objection to providing the abortifacient coverage using words of the organization's own choice.

"Eliminating the requirement of using the government's form does not eliminate moral liability for facilitating coverage of these abortifacient drugs," said Jeff Mateer, general counsel of Liberty Institute. "These new regulations are a mere hand wave to Americans who, inspired by their deep religious commitment, oppose providing drugs that may kill an unborn baby."

Last month, in the wake of the Hobby Lobby and Wheaton College Supreme Court decisions prohibiting the Obama Administration from forcing religious employers to facilitate or provide coverage for these abortifacient drugs, the administration announced that it would issue new regulations that would protect religious employers' religious freedom. Those new regulations, issued today, keep the same fundamental system in place to which so many employers have objected.

Under the "religious accommodation," religious organizations could submit a form that would trigger a requirement that the organization's insurance provider cover the objectionable drugs. Many faith-based organizations objected that forcing their insurance providers to cover drugs like Plan B and Ella was no less morally objectionable than including the drugs directly in the organizations' health insurance policies.

Liberty Institute is a nonprofit legal group dedicated to defending and restoring religious liberty across America — in our schools, for our churches, in the military and throughout the public arena. Liberty's vision is to reestablish religious liberty in accordance with the principles of our nation's Founders. For information, visit www.LibertyInstitute.org.

Logo - http://photos.prnewswire.com/prnh/20120523/DC12743LOGO-b


'/>"/>
SOURCE Liberty Institute
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Liberty Design Secures GSA Award, to Supply Federal Agencies
2. New England Laser Options Adds On Professional Hair Removal with the Astanza Liberty IPL System
3. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
4. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
5. The American Council for Patient Liberty on medical marijuana vending machines
6. Liberty Dialysis Celebrates Milestone 1,000th Patient in Peritoneal Dialysis Program
7. Incentivated Helps Scottish Government Service Consumers by SMS
8. Government Affairs & Public Policy Groups Playing Critical Role in Patient Engagement, Reports Best Practices, LLC
9. State Governments May Spend $55 Billion on Hepatitis C Medications
10. Government Testing Error Forces Delay in Planned Launch of New MSA Air Masks
11. AMRI Awarded Development and Manufacture Contract from the UK Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
(Date:9/7/2017)...  Eli Lilly and Company (NYSE: ... to more efficiently focus resources on developing new ... workforce reductions, including those from a U.S. voluntary ... 3,500 positions. With the streamlining ... approximately $500 million that will begin to be ...
Breaking Medicine Technology:
(Date:9/26/2017)... Ore. (PRWEB) , ... September 26, 2017 , ... ... Provider (CSP), today announced the Atmosera Release Management as a Service ... a Service or PaaS environments. Customers include any companies, e-tailers, and web development ...
(Date:9/26/2017)... ... September 26, 2017 , ... Two innovative companies ... new and different, it is scientifically proven as well: ABAlife™. Euromed SA, a ... an exclusive license agreement with BioTherapeutics Inc. for patented technology for absiscic acid ...
(Date:9/26/2017)... ... 2017 , ... After a summer-long contest to crown the ... Drivers proudly announced the winners of the HEROtini Mocktail Challenge at the Stockton ... the challenge of competing in three categories: Best HEROtini Mocktail, Top HEROtini Bartender, ...
(Date:9/26/2017)... Falls Church, VA (PRWEB) , ... September 26, 2017 , ... ... FDAnews and Cerulean Associates LLC **, Dec. 5-6, 2017 – Arlington, VA, http://www.fdanews.com/fdadataintegrity ... its investigators: “If initial findings indicate the firm’s electronic records may not be trustworthy ...
(Date:9/26/2017)... ... September 26, 2017 , ... Dr. Kovatis, ... of the Leg, Ankle, and Foot Section of the Department of Orthopedic Surgery ... orthopedic surgeon at Hackensack UMC performing total ankle replacements. Because of this, Dr. ...
Breaking Medicine News(10 mins):